Home > Healthcare > Medical Devices > Diagnostic Devices > Point of Care Testing Market

Point of Care Testing Market Size

  • Report ID: GMI3086
  • Published Date: Jul 2023
  • Report Format: PDF

Point of Care Testing Market Size

Point Of Care Testing Market size was over USD 38.5 billion in 2022 and is poised to witness 7% CAGR from 2023 to 2032 driven by the rising prevalence of multiple medical diseases across developing countries.


The rising frequency of infectious illnesses and chronic ailments, such as cardiovascular diseases, particularly in India and Africa, has increased the demand for point of care testing. According to the WHO report, in 2021, around 37.7 million people suffered from HIV, with more than two-thirds of them (25.4 million) residing in developing countries, such as Africa and India, among others. Similarly, the Ebola virus disease pandemic in West Africa caused massive economical disruptions and many deaths. The diagnostic management of these illnesses relies heavily on point of care testing technologies.

Point of Care Testing Restraints

The rising need for timely and efficient patient management, especially in emergency settings has fueled the adoption of point of care testing (POCT) devices. The growing advancements in technology along with the surging shift towards personalized medicine has led to the rising trend of decentralizing healthcare services. Depending on the kind and nature of the sample or test, the product designs make use of a wide range of engineering applications and technologies. The rise in the overall cost of product development due to cartridge integration for increasing the connectivity between the two components.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Point of care testing industry was valued at USD 38.6 billion in 2022 and is estimated to expand at 7% CAGR from 2023 to 2032 owing to the increasing prevalence of infectious diseases across developing countries.

The glucose monitoring segment accounted for 24.9% revenue share of the market in 2022 and is estimated to reach USD 19.2 billion by 2032 driven by the growing adoption of portable, highly convenient, and cost-effective as well as rapid POC glucose tests.

North America held 47.6% share of the market in 2022 and is anticipated to amass more than USD 35.6 billion by 2032 owing to the rising R&D investments and surge in private funding for healthcare infrastructure development.

Some of the top companies engaged in the industry are Becton, Dickinson and Company, Abbott Laboratories, F. Hoffmann-La Roche, Abaxis, ACON Laboratories, Inc, BioMerieux SA, Bio-Rad Laboratories, Inc, HemoCue AB (Danaher Corporation), Dexcom, Inc, and Medtronic Plc,

Point of Care Testing Market Scope

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 20
  • Tables & Figures: 921
  • Countries covered: 30
  • Pages: 431
 Download Free Sample